Glomerulonephropathy Database: The CureGN Study

Cure Glomerulonephropathy

Protocol Description

The objective of this program is to advance the diagnosis and care of patients with glomerular disease by collecting information and biospecimens that can be studied by researchers. A multi-center consortium, the Cure Glomerulonephropathy Network (CureGN) has established an infrastructure to support the study of glomerular disease and to recruit people with glomerular conditions to participate as members of its database.

Eligibility Criteria

Subject to certain exclusion criteria, this study is accepting participants of all ages who have been diagnosed with one of the following glomerular conditions within 5 years of study enrollment: minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), or immunoglobulin A nephropathy (IgAN).
Males and Females: All ages


At annual visits with a member of the study team, participants’ medical records, medicines, and disease progression will be reviewed, and quality of life assessments will be done. Blood and urine samples will also be collected. In each of the first 3 years, participants will have an annual office visit and 2 remote visits, spaced about 4 months apart. After that, annual in-person visits will continue with a remote visit at the 6-month interval. Optional monthly check-ins may also be done via text messaging.
Visits: 1 per year, with 1 or 2 remote visits occurring in between, according to the study protocol
Duration: Open ended

Status: Open to Enrollment

Source(s) of Support

Cure Glomerulonephropathy Network
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health

Primary Investigator

Michael Moritz, MD

Contact Information

For more information about the study or enrollment, please contact:
Vibha Chauhan, PhD, CCRP, CCRC